Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ Áß¾Ó Á¶Á¦ ¾à±¹ ÀÚµ¿È ½ÃÀåÀº 2025³â 7¾ï 5,080¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, ¿¹Ãø ±â°£ µ¿¾È 13.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2032³â±îÁö 17¾ï 9,943¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. Áß¾Ó Á¶Á¦ ¾à±¹ ÀÚµ¿È¶õ, ÁýÁßÇü ¾à±¹¿¡¼ÀÇ Ã³¹æÀü ó¸® ÇÁ·Î¼¼½º¸¦ ÇÕ¸®ÈÇϱâ À§ÇÑ ¼±Áø ±â¼ú°ú ·Îº¿ ½Ã½ºÅÛÀÇ »ç¿ëÀ» ¸»ÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛ¿¡ ÀÇÇØ, º¹¼öÀÇ ¼Ò¸Å ¾à±¹À̳ª ¿Ü·¡ ¾à±¹ÀÇ Ã³¹æÀüÀ» Àϰý ó¸®ÇÏ´Â °ÍÀÌ °¡´ÉÇØÁ®, È¿À²¼º Çâ»ó, Åõ¾à ¹Ì½º »è°¨, ½Å¼ÓÇÑ ¹è´ÞÀÌ ½ÇÇöµË´Ï´Ù. Á¶Á¦, Æ÷Àå ¹× ¶óº§¸µ µîÀÇ ÀÛ¾÷À» ÀÚµ¿ÈÇÔÀ¸·Î½á ¿öÅ©Ç÷ο츦 °ÈÇϰí ÀΰǺñ¸¦ ÃÖ¼ÒÈÇϸç ÀǾàǰ ¾÷¹«ÀÇ Á¤È®µµ¸¦ ³ôÀÔ´Ï´Ù.
ó¹æÀü ¸Å¼ö Áõ°¡
Áß¾Ó Á¶Á¦ ¾à±¹ ÀÚµ¿È´Â È¿À²¼ºÀ» Çâ»ó½ÃŰ°í ¼öÀÛ¾÷À¸·Î ÀÎÇÑ ½Ç¼ö¸¦ ÁÙÀÓÀ¸·Î½á ¾÷¹«ÀÇ ÇÕ¸®È¸¦ Áö¿øÇÕ´Ï´Ù. º¸´Ù ½Å¼ÓÇϰí Á¤È®ÇÑ Á¶Á¦ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÀÚµ¿È ½Ã½ºÅÛ¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÀǾàǰÀÇ ¾ÈÀü¼ºÀ» °ÈÇϰí Á¶Á¦ ½Ç¼ö¸¦ ÃÖ¼ÒÈÇÑ´Ù´Â ±ÔÁ¦»óÀÇ ¾Ð·ÂÀÌ Ã¤¿ëÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¾à±¹¿¡¼´Â ó¹æÀü ¸Å¼öÀÇ Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ È®À强ÀÌ ³ôÀº ¼Ö·ç¼ÇÀ» ¿ä±¸ÇÏ´Â °æÇâÀÌ °ÇØÁö°í ÀÖ½À´Ï´Ù. ±× °á°ú, ÀÚµ¿È ±â¼úÀº ±Ù´ëÀûÀÎ ¾à±¹ ¾÷¹«¿¡ ÇʼöÀûÀÎ °ÍÀÌ µÇ°í ÀÖ½À´Ï´Ù.
¼Ò±Ô¸ð ¾à±¹¿¡¼ÀÇ Á¦ÇÑÀûÀΠä¿ë
¼Ò±Ô¸ð ¾à±¹Àº ºñ¿ë Á¦¾à°ú ÀÎÇÁ¶ó Á¦ÇÑÀ¸·Î ÀÎÇØ Á¾Á¾ Áß¾Ó Á¶Á¦ ¾à±¹ ÀÚµ¿ÈÀÇ µµÀÔ¿¡ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ¸¹Àº µ¶¸³ ¾à±¹Àº Á¦ÇÑµÈ ¿¹»êÀ¸·Î ¿î¿µµÇ°í Àֱ⠶§¹®¿¡ ´ë±Ô¸ð ±â¼ú ÅõÀÚ´Â ¾î·Æ½À´Ï´Ù. ¶ÇÇÑ ±âÁ¸ ¿öÅ©Ç÷ο쿡 ÀÚµ¿È¸¦ ÅëÇÕÇÏ´Â °ÍÀÇ º¹À⼺µµ À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¾÷¹«»óÀÇ È¥¶õ ¹× ³ëµ¿·ÂÀÇ ÀûÀÀ¿¡ °üÇÑ ¿ì·Á°¡ ½Å¼ÓÇÑ Ã¤¿ëÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼Ò±Ô¸ð ¾à±¹ÀÇ °æ¿µÀÚ »çÀÌ¿¡¼´Â º¯È¿¡ ´ëÇÑ Àνİú ÀúÇ×ÀÌ ÇÑÁ¤ÀûÀÎ °Íµµ µµÀÔÀ» ´ÊÃß°í ÀÖ½À´Ï´Ù.
È®´ëÇÏ´Â ¼Ò¸Å üÀÎ ¾à±¹
ÁÖ¿ä ¼Ò¸Å ¾à±¹ üÀÎÀÇ È®´ë´Â Áß¾Ó Á¶Á¦ ¾à±¹ ÀÚµ¿È µµÀÔÀÇ Å« ±âȸ°¡ µÇ°í ÀÖ½À´Ï´Ù. ´ëÇü ¾à±¹ ¼Ò¸Å¾÷ÀÚµéÀº È¿À²À» ÃÖÀûÈÇϰí ÀΰǺñ¸¦ ÁÙÀ̱â À§ÇØ ÀÚµ¿È ÅõÀÚ¸¦ ´Ã¸®°í ÀÖ½À´Ï´Ù. Ç¥ÁØÈµÈ ÇÁ·Î¼¼½º¿Í ÁýÁß Á¶Á¦ ¸ðµ¨À» ÅëÇØ ¼Ò¸Å üÀÎÀº ´õ ³ôÀº Á¤È®µµ ¹× ¼Óµµ¸¦ ´Þ¼ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÚµ¿È¸¦ ÅëÇØ ¿©·¯ °ÅÁ¡¿¡¼ Àϰü¼ºÀ» À¯ÁöÇÏ°í ±ÕÀÏÇÑ ¼ºñ½º ǰÁúÀ» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ó¹æÀü Á¶Á¦ÀÇ ¼ö¿ä°¡ ³ô¾ÆÁü¿¡ µû¶ó ´ëÇü Á¶Á¦ ¾à±¹ üÀÎÀº ¾÷¹«ÀÇ ÇÕ¸®È¸¦ À§ÇØ ÀÚµ¿È¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù.
µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎÁ¤º¸ º¸È£¿¡ ´ëÇÑ ¿ì·Á
»çÀ̹ö À§Çù ¹× µ¥ÀÌÅÍ À¯ÃâÀÇ À§ÇèÀº ÀÚµ¿È¸¦ äÅÃÇÏ´Â ¾à±¹¿¡ ½É°¢ÇÑ ¿ì·Á°¡ ÀÖ½À´Ï´Ù. ±â¹Ð¼ºÀÌ ³ôÀº ÀÇ·á Á¤º¸¿¡ ´ëÇÑ ºÎÁ¤ ¾×¼¼½º´Â ÄÄÇöóÀ̾𽺠À§¹ÝÀ̳ª ¹ýÀû Ã¥ÀÓÀ¸·Î À̾îÁú °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. °Ô´Ù°¡ µ¥ÀÌÅÍÀÇ ¹«°á¼ºÀ̳ª ½Ã½ºÅÛÀÇ Ãë¾à¼º¿¡ ´ëÇÑ ¿ì·Á´Â ä¿ë¿¡ ¹æÇذ¡ µË´Ï´Ù. ¾à±¹Àº ȯÀÚÀÇ ±â·ÏÀ» º¸È£ÇÏ°í ½Å·Ú¸¦ À¯ÁöÇϱâ À§ÇØ °ß°íÇÑ º¸¾È ÇÁ·ÎÅäÄÝÀ» È®º¸ÇØ¾ß ÇÕ´Ï´Ù. µðÁöÅÐ °Ç° µ¥ÀÌÅÍÀÇ º¸È£´Â ±â¾÷¿¡ ÀÖ¾î¼ Áß¿äÇÑ °úÁ¦ÀÔ´Ï´Ù.
COVID-19ÀÇ ¿µÇâ
COVID-19ÀÇ ´ëÀ¯ÇàÀº ó¹æÀü ¼ö¿ä Áõ°¡ ¹× ¾÷¹«»óÀÇ Á¦¾àÀ¸·ÎºÎÅÍ ¾à±¹¿¡¼ ÀÚµ¿È µµÀÔÀ» °¡¼Ó½ÃÄ×½À´Ï´Ù. ºÀ¼â ¹× »çȸÀû °Å¸®µÎ±â Á¶Ä¡´Â ÇÕ¸®ÈµÈ ¾à±¹ ¿öÅ©Ç÷οìÀÇ Çʿ伺À» °Á¶Çß½À´Ï´Ù. ÀÚµ¿È´Â È¿À²ÀûÀΠó¹æÀü 󸮸¦ À¯ÁöÇÏ¸é¼ ÀÎÀû Á¢ÃËÀ» ÁÙÀ̱â À§ÇÑ Áß¿äÇÑ ¼Ö·ç¼ÇÀÌ µÇ¾ú½À´Ï´Ù. ¾à±¹Àº ±ÞÁõÇϴ ó¹æÀüÀ» ¾ÈÀüÇÏ°Ô °ü¸®Çϱâ À§ÇØ ÁýÁßÇü ¸ðµ¨À» äÅÃÇÏ´Â °æÇâÀÌ °ÇØÁ³½À´Ï´Ù. ÆÒµ¥¹Í ÀÌÈÄ¿¡´Â ¾à±¹ÀÌ »õ·Î¿î ¾÷¹« ±Ô¹ü¿¡ ÀûÀÀÇϱ⠶§¹®¿¡ ÀÚµ¿È¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ°¡ ¿¹»óµË´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¼ÒÇÁÆ®¿þ¾î ºÐ¾ß°¡ ÃÖ´ë°¡ µÉ Àü¸Á
¼ÒÇÁÆ®¿þ¾î ºÐ¾ß´Â ¿öÅ©Ç÷οì È¿À²À» ÃÖÀûÈÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °í±Þ ¾à±¹ °ü¸® ½Ã½ºÅÛÀº ÀÚµ¿ Á¶Á¦ ¼Ö·ç¼Ç°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. Àç°í ÃßÀû, ó¹æ È®ÀÎ, ȯÀÚ µ¥ÀÌÅÍ °ü¸® µîÀÇ ±â´ÉÀ¸·Î ¾÷¹« È¿À²ÀÌ Çâ»óµË´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö´Â °ÍÀº ¾à±¹ ÀÚµ¿ÈÀÇ ¼ÒÇÁÆ®¿þ¾î äÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È º´¿ø ¾à±¹ ºÐ¾ßÀÇ CAGRÀÌ °¡Àå ³ô¾ÆÁú Àü¸Á
¿¹Ãø ±â°£ µ¿¾È È¿À²ÀûÀÎ Åõ¾à °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó º´¿ø ¾à±¹ ºÐ¾ß°¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÇÊ¿äÇÕ´Ï´Ù. º´¿øÀº ´ë·®ÀÇ Ã³¹æÀüÀ» ó¸®ÇÏ°í ½ÃÀÇÀûÀýÇÑ Á¶Á¦¸¦ È®º¸Çϱâ À§ÇØ ÀÚµ¿ÈµÈ ¼Ö·ç¼ÇÀ» ÇÊ¿ä·Î ÇÕ´Ï´Ù. º´¿ø ¾à±¹ÀÇ ÀÚµ¿È ÅëÇÕÀº ¿öÅ©Ç÷οìÀÇ Á¤È®¼ºÀ» ³ôÀ̰í Åõ¾à ½Ç¼ö¸¦ ÃÖ¼ÒÈÇÕ´Ï´Ù. Áõ°¡Çϴ ȯÀÚÀÇ ÀÔ¿ø°ú º¹ÀâÇÑ Ä¡·á ·¹Áö¸àÀº ¿øÈ°ÇÑ ¿î¿µÀ» À§ÇÑ °íµµÀÇ ÀÚµ¿È ½Ã½ºÅÛÀ» ÇÊ¿ä·Î ÇÕ´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº ±Þ¼ÓÈ÷ È®´ëÇÏ´Â ÇコÄÉ¾î ºÎ¹®°ú ¼ºÀåÇÏ´Â Á¦¾à¾÷°è¿¡ ÀÇÇØ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÇコÄɾîÀÇ µðÁöÅÐÈ ¹× ÀÚµ¿È¸¦ ÃßÁøÇÏ´Â Á¤ºÎÀÇ ´ëó°¡ ÀÌ Áö¿ªÀÇ ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ ºÎ´ã Áõ°¡´Â ó¹æÀü·®ÀÇ Áõ°¡·Î À̾îÁ® È¿À²ÀûÀÎ Á¶Á¦ ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÇコÄɾî ÀÎÇÁ¶ó ¹× ¾à±¹ ÀÚµ¿È¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ´Â °í±Þ ÀÇ·á ÀÎÇÁ¶ó¿Í ÀÚµ¿ÈÀÇ µµÀÔÀ» Áö¿øÇÏ´Â °·ÂÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ ¿öÅ© ¶§¹®ÀÔ´Ï´Ù. ´ëÇü ¾à±¹ üÀΰú ÇコÄÉ¾î °ø±ÞÀÚÀÇ Á¸Àç°¡ ÀÚµ¿È ½Ã½ºÅÛ¿¡ ´ëÇÑ ÅõÀÚ¸¦ °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºñ¿ëÀÇ »ó½ÂÀ¸·Î ¾à±¹Àº Áß¾Ó Á¶Á¦ ¾à±¹ ÀÚµ¿È µîÀÇ È¿À² Á߽à ¼Ö·ç¼ÇÀ» äÅÃÇÏ°Ô µÇ¾î ÀÖ½À´Ï´Ù. ó¹æÀüÀÇ Á¤È®¼º°ú ȯÀÚ ¾ÈÀü¼º¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡°¡ ä¿ë·üÀ» ´õ¿í ²ø¾î¿Ã¸®°í ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Central Fill Pharmacy Automation Market is accounted for $750.80 million in 2025 and is expected to reach $1799.43 million by 2032 growing at a CAGR of 13.3% during the forecast period. Central Fill Pharmacy Automation refers to the use of advanced technologies and robotic systems to streamline the prescription fulfilment process at centralized pharmacy locations. This system enables bulk processing of prescriptions for multiple retail or outpatient pharmacies, improving efficiency, reducing medication errors, and ensuring faster delivery. By automating tasks such as dispensing, packaging, and labelling, it enhances workflow, minimizes labour costs, and supports higher accuracy in pharmaceutical operations.
Rising prescription volume
Central fill pharmacy automation helps streamline operations by improving efficiency and reducing manual errors. The growing demand for faster and accurate dispensing solutions is fuelling investment in automated systems. Additionally, regulatory pressure to enhance medication safety and minimize dispensing errors is boosting adoption. Pharmacies are increasingly seeking scalable solutions to accommodate higher prescription loads. As a result, automation technologies are becoming essential for modern pharmacy operations.
Limited adoption in small pharmacies
Smaller pharmacies often face challenges in adopting central fill automation due to cost constraints and infrastructure limitations. Many independent pharmacies operate with limited budgets, making significant technological investments difficult. The complexity of integrating automation with existing workflows can be another barrier. Additionally, concerns over operational disruption and workforce adaptation hinder rapid adoption. Limited awareness and resistance to change among smaller pharmacy owners also slow down implementation.
Growing retail chain pharmacies
The expansion of large retail pharmacy chains presents a significant opportunity for central fill automation adoption. Major pharmacy retailers are increasingly investing in automation to optimize efficiency and reduce labour costs. Standardized processes and centralized dispensing models enable retail chains to achieve higher accuracy and speed. Moreover, automation helps maintain consistency across multiple locations, ensuring uniform service quality. As the demand for prescription fulfilment grows, large pharmacy chains are adopting automation to streamline operations.
Data security and privacy concerns
The risk of cyber threats and data breaches poses a significant concern for pharmacies adopting automation. Unauthorized access to sensitive medical information can lead to compliance violations and legal liabilities. Additionally, concerns over data integrity and system vulnerabilities can deter adoption. Pharmacies must ensure robust security protocols to protect patient records and maintain trust. Safeguarding digital health data is a significant challenge for the company.
Covid-19 Impact
The COVID-19 pandemic accelerated the adoption of automation in pharmacies due to rising prescription demand and operational constraints. Lockdowns and social distancing measures highlighted the need for streamlined pharmacy workflows. Automation became a key solution to reduce human contact while maintaining efficient prescription fulfilments. Pharmacies increasingly turned to centralized models to manage surging prescription volumes safely. Post-pandemic, continued investment in automation is expected as pharmacies adapt to new operational norms.
The software segment is expected to be the largest during the forecast period
The software segment is expected to account for the largest market share during the forecast period, due to its critical role in optimizing workflow efficiency. Advanced pharmacy management systems enable seamless integration with automated dispensing solutions. Features such as inventory tracking, prescription verification, and patient data management enhance operational effectiveness. The rising focus on cloud-based platforms is further driving software adoption in pharmacy automation.
The hospital pharmacies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospital pharmacies segment is predicted to witness the highest growth rate, due to the increasing need for efficient medication management systems. Hospitals require automated solutions to handle high prescription volumes and ensure timely dispensing. The integration of automation in hospital pharmacies enhances workflow accuracy and minimizes medication errors. Rising patient admissions and complex treatment regimens necessitate advanced automation systems for smooth operations.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its rapidly expanding healthcare sector and growing pharmaceutical industry. Government initiatives promoting healthcare digitization and automation are driving market expansion in the region. The rising burden of chronic diseases is leading to higher prescription volumes, necessitating efficient dispensing solutions. Increasing investments in healthcare infrastructure and pharmacy automation are further boosting market growth.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its advanced healthcare infrastructure and strong regulatory framework supporting automation adoption. The presence of leading pharmacy chains and healthcare providers is accelerating investment in automated systems. Rising healthcare costs are pushing pharmacies to adopt efficiency-driven solutions such as central fill automation. The growing demand for prescription accuracy and patient safety is further propelling adoption rates.
Key players in the market
Some of the key players profiled in the Central Fill Pharmacy Automation Market include Omnicell, ARxIUM, ScriptPro, RxSafe, Capsa Healthcare, McKesson Corporation, Swisslog Healthcare, Parata Systems, Innovation Associates, KUKA AG, Becton, Dickinson and Company (BD), Cornerstone Automation Systems, LLC (CASI), Tension Packaging & Automation, R/X Automation Solutions, and Yuyama Co., Ltd.
In May 2025, Omnicell, Inc. announced new products designed to streamline workflows and enhance inventory visibility and management in perioperative and clinic settings. These products, which leverage RFID tracking and intelligent software workflows, expand Omnicell's connected platform that is intended to automate medication management processes and deliver intelligent insights to drive clinical and operational outcomes across all settings of care.
In May 2025, Capsa Healthcare announced that Houston, TX-based Harris Health has chosen Capsa as its design and installation partner for a new automated central fill prescription processing solution. The partnership will significantly advance Harris Health's medication delivery capabilities for the health system's nearly 10,000 employees and more than 250,000 patients.